Companies · Listed company · 🇮🇳

Dishman Carbogen Amcis Limited

DCAL · NSE · ₹150 a share (close of 01 Oct 2026)

Available company data, source links and archived checks for Dishman Carbogen Amcis Limited. Read each source and date: a past check is not a fresh review, and some earlier figures have incomplete source details.

Revenue fell 4.3%; Net loss was ₹57.88 crore.

Quarter ended 2026-06-30 · consolidated · Company filing

📅 Next event: board meeting — Wed 07 Oct. As filed with the exchange.
Recorded quarterly figures
QuarterRevenue / incomeYoY ProfitYoYNet marginSource
Jun 2026Revenue: ₹678 cr-4.3%Net profit: ₹-58 cr-347.2%-8.5%Company filing source
Mar 2026Revenue: ₹851 cr+18.9%Net profit: ₹22 cr-49.5%2.6%Company filing source
Dec 2025Revenue: ₹720 cr—Net profit: ₹-13 cr—-1.8%Company filing source
Sep 2025Revenue: ₹653 cr—Net profit: ₹65 cr—10.0%Company filing source
Jun 2025Revenue: ₹708 cr+35.2%Net profit: ₹23 cr—3.3%Company filing source
Mar 2025Revenue: ₹716 cr—Net profit: ₹43 cr—6.0%Company filing source

YoY means change from the same quarter a year earlier. — means no comparable figure is available. Older entries with incomplete source details have not been revalidated under the current checks.

Who holds it — from the filings
Adimans Technologies LLP 59.3%Mukul Mahavir Agrawal 5.5%Massachusetts Institute Of Technology 2.3%Hbm Healthcare Investments (Cayman) Ltd 2.2%Hsbc Mutual Fund - Hsbc Flexi Cap Fund 1.4%register as filed 2026-06-30
Filing timeline — what the company told the exchange

Follow this company without reading every document yourself.

Keep its available filings, dated fact checks and disclosure alerts together. Your saved country sets your market and its research schedule.

Start free — first week on us →
India ₹149/month · Rest of world US$4.99/month after the free trial · research, not investment advice · cancel any time
Or just the free morning: three facts checked against filings, every trading day, in your inbox.

Company data and archived claim checks are shown with available sources. Check the source and date before relying on a figure. This is not investment advice or a recommendation. Investment in securities markets is subject to market risks. Research on this site is produced with substantial use of AI. Terms, disclosures and grievances